The Cancer

Don't Miss

What MRD Testing Can Imply for Sufferers With Breast Most cancers and Survivors

Minimal residual illness, or MRD, testing can supply psychological consolation to sufferers with breast most cancers and survivors in addition to perception into potential remedy...

A Sufferers Navigation Information to Stage 2 Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC) is the commonest kind of kidney most cancers, accounting for roughly 70–80% of circumstances. Stage 2 signifies that the...

FDA Quick Tracks IBI3003 For Relapsed/Refractory Myeloma

The U.S. Meals and Drug Administration (FDA) has granted quick observe designation to IBI3003, an anti-GPRC5D/BCMA/CD3 tri-specific antibody, to expedite the event and evaluate of...

Vital Information

Facts

Latest Articles

FDA Quick Tracks LBL-034 in Relapsed or Refractory A number of Myeloma

The U.S. Meals and Drug Administration has granted quick observe designation to the investigational remedy LBL-034 to facilitate the event of a...

A Breast Most cancers Survivor’s First Brush with Pores and skin Most cancers

Self-checks for pores and skin most cancers, in addition to common check-ups with a dermatologist, are necessary for breast most cancers survivors....

Caregivers Typically Overlook Their Personal Well being Whereas Supporting Sufferers

Dr. Tracy Proverbs-Singh, a gastrointestinal oncologist at John Theurer Most cancers Heart, mentioned how caregivers usually overlook their very own well being...

Most Sufferers With HER2+ Breast Most cancers Miss Normal Remedy, Research Exhibits

Cleveland Clinic researchers have discovered that just about two-thirds of sufferers with HER2-positive metastatic breast most cancers didn't obtain the guideline-recommended normal...

Knowledgeable insights into Biomarker-Pushed Care and Rising Targets in GI Most cancers

Dr. Suneel Kamath, a gastrointestinal medical oncologist at Cleveland Clinic in Ohio and an assistant professor of drugs on the Cleveland Clinic...

Hot Topics